Northwire Canada EditionThursday, August 6, 2026
Sign inSubscribe
Northwire
⌕
ARTG 37.67 +7.3% SAGE 0.120 +4.3% NTR 93.88 −0.3% ERO 42.71 +4.6% EDR 12.55 +7.1% IFOS 2.23 −0.5% URE 1.80 −2.2% AAUC 27.50 +4.3% IMR 0.145 +3.6% EQX 14.50 +7.4% OGC 37.67 +6.8% TFPM 43.89 +4.4% SGD 15.42 +5.4% BKM 2.55 +3.2% OR 45.20 +4.4% CDE 24.46 +7.2% ARTG 37.67 +7.3% SAGE 0.120 +4.3% NTR 93.88 −0.3% ERO 42.71 +4.6% EDR 12.55 +7.1% IFOS 2.23 −0.5% URE 1.80 −2.2% AAUC 27.50 +4.3% IMR 0.145 +3.6% EQX 14.50 +7.4% OGC 37.67 +6.8% TFPM 43.89 +4.4% SGD 15.42 +5.4% BKM 2.55 +3.2% OR 45.20 +4.4% CDE 24.46 +7.2%
Regulatory

Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq

By The Northwire Desk — AI Analysis Dec 18, 2025 · 07:30 CYBN · 9.43 CYBIN INC.
CYBN · Price

Executive Summary

  • Cybin Inc. will voluntarily transfer its U.S. listing from NYSE American to the Nasdaq Global Market, effective January 5 2026.
  • The ticker symbol will change from “CYBN” to “HELP” on both Nasdaq and Cboe Canada as of the same date.
  • The move is presented as a step in Cybin’s evolution into a global pharmaceutical company.

Key Details

  • Listing Transfer: NYSE American trading will cease at market close on January 4 2026; Nasdaq trading will commence at market open on January 5 2026.
  • Ticker Change: The common shares will switch from “CYBN” to “HELP” on both Nasdaq and Cboe Canada starting January 5 2026.
  • Rationale (CEO Quote): Interim CEO Eric So stated the transfer “marks the next step in the evolution of Cybin into a global pharmaceutical company.”
  • Regulatory Note: Neither Cboe Canada nor NYSE American have approved or disapproved the contents of this release.

Notable Quotes

“We are pleased to join the community of global pharmaceutical companies listed on Nasdaq and thank the NYSE American for supporting the company over the last four years since our initial listing,” – Eric So, interim chief executive officer, Cybin Inc.

Read the original news release →

More from CYBIN INC.

Dec 30, 2025 · 15:33

Cybin Initiates At-The-Market Equity Program of up to US$100 Million

Financings Nov 13, 2025 · 07:20

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

Earnings Nov 06, 2025 · 07:30

Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025

Earnings Oct 31, 2025 · 16:19

Cybin Announces Closing of $175 Million Registered Direct Offering

Financings Oct 28, 2025 · 08:00

Cybin Announces $175 Million Registered Direct Offering

Financings